Search Results - "Sigin, V."

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity by Tanas, A.S., Kekeeva, T., Sigin, V.O., Kuznetsova, E.B., Poddubskaya, E., Trotsenko, I., Zaletaev, D.V., Strelnikov, V.V.

Get full text

The potential of DNA methylation markers in the study of obesity by Nikolaeva, A. F., Petrova, K. O., Vasyukova, O. V., Guseinova, R. M., Minniakhmetov, I. R., Khusainova, R. I., Mokrysheva, N. G., Sigin, V. O.

“…Obesity is a complex, heterogeneous, actively progressive disease manifested by excessive formation of adipose tissue in the body and usually has a high…”
Get full text

CHANGES IN DNA METHYLATION PROFILE IN TAMOXIFEN-RESISTANT MCF-7 SUBLINES by Andreeva, О. Е., Sigin, V. О., Strelnikov, V. V., Tanas, A. S., Scherbakov, A. M., Krasilnikov, M. A.

“…Abstract Introduction. We have previously shown the feasibility of hormonal resistance horizontal distribution from cell to cell, with the joint cultivation of…”
Get full text

1143P Virtual amplicons for methylation-sensitive restriction enzyme quantitative PCR (MSRE-qPCR) derived from genome-wide DNA methylation sequencing: Application to prediction of breast cancer neoadjuvant chemotherapy response by Kalinkin, A.I., Sigin, V., Ignatova, E., Tanas, A.S., Strelnikov, V.V.

Get full text

12P DNMT1/3-targeting microRNAs are over-expressed in the exosomes of estrogen-resistant breast cancer cells by Sorokin, D.V., Andreeva, O.E., Mikhaevich, E.I., Shchegolev, Y., Sigin, V., Strelnikov, V.V., Tanas, A., Scherbakov, A.M., Krasil’nikov, M.

Get full text

70P A DNA methylation markers panel for prediction of luminal B breast cancer neoadjuvant chemotherapy response by quantitative PCR by Nikolaeva, A., Sigin, V., Kalinkin, A.I., Litviakov, N.V., Slonimskaya, E., Tsyganov, M., Kharitonova, A., Vinogradov, I., Vinogradov, M., Strelnikov, V.V., Tanas, A.S.

Get full text

93P IRF4 gene promoter methylation predicts efficacy of luminal B breast tumours neoadjuvant chemotherapy by Sigin, V., Kalinkin, A.I., Litviakov, N.V., Kuznetsova, E., Simonova, O., Volodin, I., Slonimskaya, E., Tsyganov, M., Vinogradov, I.I., Vinogradov, M., Vinogradov, I.Y., Zaletaev, D.V., Strelnikov, V.V., Tanas, A.S.

Get full text

57PLeukotriene B4 receptors abnormal gene expression is associated with either shorter or longer survival in breast cancer patients depending on the intrinsic tumour molecular subtype by Kalinkin, A I, Nemtsova, M V, Zaletaev, D V, Sigin, V O, Ignatova, E, Kuznetsova, E B, Strelnikov, V V, Tanas, A S

“…Abstract Background Leukotrienes receptor signaling is involved in tumor development and progression. Expression of leukotriene B4 receptors 1 and 2 (LTB4R and…”
Get full text

178PXmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity by Tanas, A S, Kekeeva, T, Sigin, V O, Kuznetsova, E B, Poddubskaya, E, Trotsenko, I, Zaletaev, D V, Strelnikov, V V

Get full text

58PA seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer by Sigin, V O, Kalinkin, A I, Ignatova, E, Sycheva, A V, Vinogradov, I I, Vinogradov, M I, Vinogradov, I Y, Zaletaev, D V, Strelnikov, V V, Tanas, A S

“…Abstract Background Nowadays anthracycline and taxane-based chemotherapy remains the standard of care for TNBC, with pathological complete response (pCR) rates…”
Get full text

80PDNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy by Sigin, V O, Strelnikov, V V, Litviakov, N V, Simonova, O A, Volodin, I V, Slonimskaya, E M, Tanas, A S, Zaletaev, D V, Kuznetsova, E B, Tsyganov, M M

Get full text

Assessing the Association of the Degree of DNA Methylation and the Frequency of Chromosomal Aberrations in Human Lymphocytes in a Single Irradiation of Blood In Vitro by Tsymbal, O. S., Isubakova, D. S., Bronikovskaya, E. V., Nikolaeva, A. F., Sigin, V. O., Kalinkin, A. I., Startseva, Zh. A., Litviakov, N. V., Milto, I. V., Takhauov, R. M.

“…The most sensitive biomolecule under radiation exposure is DNA, whose damage manifests itself in the form of chromosomal aberrations (CA). The processes of DNA…”
Get full text

DNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy by Sigin, V.O., Strelnikov, V.V., Litviakov, N.V., Simonova, O.A., Volodin, I.V., Slonimskaya, E.M., Tanas, A.S., Zaletaev, D.V., Kuznetsova, E.B., Tsyganov, M.M.

Get full text

Design of Marker Panels for Prediction of Neoadjuvant Chemotherapy Response of Triple-Negative Breast Tumors Based on the Results of Genome-Wide DNA Methylation Screening by Kalinkin, A. I., Sigin, V. O., Ignatova, E. O., Frolova, M. A., Kuznetsova, E. B., Vinogradov, I. Y., Vinogradov, M. I., Vinogradov, I. I., Nemtsova, M. V., Zaletaev, D. V., Tanas, A. S., Strelnikov, V. V.

“…The rate of complete pathomorphological response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer is low and ranges from 30 to 40%. At the…”
Get full text

Identification of prognostically significant DNA methylation signatures in patients with various breast cancer types by Kalinkin, AI, Sigin, VO, Nemtsova, MV, Strelnikov, VV

“…Breast cancer (BC) is the most frequently diagnosed cancer and one of the major causes of female mortality. The development of prognostic models based on…”
Get full text